[Value and limitations of the study of gamma-enolase in cerebrospinal fluid as evidence of neuronal degeneration].
Elevation of the gamma-chain of the glycolytic enzyme enolase in the cerebrospinal fluid has previously been reported as a parameter for neuronal damage. The authors evaluated this by measuring gamma-enolase in the CSF of a number of patients with neurological disease known to produce neuronal damage, using a commercial radioimmuno-assay test kit. All measurements were done when gamma-enolase levels had been reported to be maximal during the course of the disease. The results suggest that, as a parameter for neuronal damage, gamma-enolase is not as reliable as reported. An elevation of gamma-enolase in the CSF seems to reflect serious disease; this could be important in differentiating encephalitis caused by Herpes Simplex virus from other viral encephalitides. A normal level of gamma-enolase does not exclude severe neuronal damage.